- 24/7 Wall St.•last year
Response Genetics has executed an asset purchase agreement with Cancer Genetics as a "stalking horse" bidder to potentially acquire all of the company's assets.
- TheStreet.com•2 years ago
These under-$10 stocks are within range of triggering big breakout trades.
- theflyonthewall.com•3 years ago
Response Genetics launches new test for cancer immunotherapy drug development
RGDX : Summary for Response Genetics, Inc. - Yahoo Finance
Response Genetics, Inc. (RGDX)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
As of 2:59PM EST. Market open.
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|